DFC Advisory Services LLC, dba TW Research Group may from time to time in our articles, reports, and interviews offer our own opinions concerning our featured companies, or the business spaces and market segments in which they operate. Any opinions we may offer are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers and viewers, and therefore should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research, and all investment decisions are solely the responsibility of the reader. We are NOT a registered broker/dealer/analyst/adviser. We hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. Our publications cannot not be construed as a recommendation to buy or sell a security or to provide any investment advice.

Our publications do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications. Trading securities involves extreme risk and requires professional guidance. TW Research Group does not give specific trading advice, and no representation or claim is made that our publications contain a thorough analysis of each security. You should discuss your asset allocation, and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser. TW Research Group LLC  encourages readers and viewers to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at: http://www.sec.gov prior to investing in anything. You should also not make any trades or decisions based upon anything said or written with regard to investments without consulting a professional financial planner/adviser. The content provided by TW Research Group is provided solely as an informational aid. Past performance is not indicative of future results. TW Research Group is not liable for any trading losses you may incur as a result of our publications, market updates, news alerts and corporate profiles. Our publications are NOT a solicitation or recommendation to buy, sell or hold securities.

This website is provided for informational purposes only and should not be construed as a solicitation or an offer to buy or sell any security or related financial instrument. The information, materials or opinions contained in this website are subject to change at any time by TW Research Group without prior notice and we are not obligated to update or keep current the information contained herein. You should consider the information on its own merits whether it is suitable for your personal needs, investment objectives, and specific circumstances. We recommend that you consult with a licensed, qualified professional before making any investment decisions.

Some of the securities mentioned on this website may not be registered in the jurisdiction in which you are located. We urge you to seek legal advice before offering or selling any unregistered security.

TW Research Group and its officers may have been compensated by or have an equity interest – restricted and/or unrestricted – in the companies referred to on this website. TW Research Group is currently engaged with Amryt Pharma, ParkerVision, Inc., TFF Pharmaceuticals, Fortress Biotech, INmune Bio, Anixa Biosciences, Lantern Pharma, LexaGene and Summit Wireless to assist with investor relations. ParkerVision has issued 200,000 warrants to TW Research Group. TFF Pharmaceuticals has issued 25,000 warrants to TW Research Group. Fortress Biotech previously paid TW Research Group $4,000 and has issued 100,000 warrants to TW Research Group. INmune Bio pays TW Research Group a monthly retainer of $2,000 and has issued 20,000 shares to TW Research Group. Anixa Biosciences pays TW Research Group a has issued 135,000 warrants to TW Research Group. Lantern Pharma pays TW Research Group a monthly retainer of $3,500. Amryt Pharma pays TW Research Group a monthly retainer of $4,000. LexaGene pays TW Research Group a monthly retainer of $2,500 and has issued 100,000 warrants to TW Research Group.

In addition, the following companies have previously compensated TW Research: Summit Wireless, Catasys Corp. (OnTrak), Dyadic Inc., BioVie, HyreCar, Hancock Jaffe, Patriot One, Bioasis, Monaker Group, FTE Networks and Muscle Maker Grill.

This website contains links to various sites of other institutions that are not affiliated with us. We provide these links because we believe they contain beneficial information. We do not control and are not responsible for the accuracy of the content of those sites. We reserve the right, in our sole discretion and without any obligation, to make any improvements to, or correct any errors or omissions in a portion of the information provided.

The information and materials available on this website has been provided by us on an “as is” basis and Tailwinds Research Group expressly disclaims any and all warranty – express or implied – including, without limitation, warranties of merchantability and fitness for a particular purpose with respect to this information or materials. In no event shall Tailwinds Research Group LLC be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind with respect to information or materials presented on this website or any of the information available through this website.

Articles, Tweets, and other information disseminated via social media are based on publicly available information only, and obtained from sources we believe to be reliable, but we cannot guarantee to be accurate nor do we purport to be complete. Because of individual objectives, articles, Tweets, or posts on Social Media accounts should not be construed as advice designed to meet the particular investment needs of any investor. Investing involves risk, and investment in small cap stocks involves significant risk. You can lose money by trading or investing in stocks covered by Tailwinds Research Group or our other social media accounts, including Twitter, LinkedIn, Stocktwits, and Facebook. Investors should be aware of these risks and consult a certified financial planner before making investment decisions. We do not recommend the purchase or sale of any securities based on information found only in this website or in our social media accounts. Articles or social media posts are not to be construed as an offer or solicitation of an offer to buy or sell the securities mentioned herein.

This website and its contents are protected by applicable copyright, patent, and trademark laws.

We are not responsible for any damage to your computer or software that results from using this website.

We have taken certain steps to provide a secure environment for your personal information on this website. Due to the nature of the internet, however, we cannot guarantee the confidentiality of such information.

This website and webpage includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this website that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” “intends,” or other words or phrases of similar import. Similarly, statements in this website that describe a company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Tailwinds Research Group LLC, its management, website and publications and online posts may contain or incorporate by reference “forward-looking statements”, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the forgoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s)” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the Companies profiled herein to differ materially from these indicated by such forward-looking statements. Certain statements contained herein constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business and financing, business trends, future operating revenues and expenses. Although Tailwinds Research Group believes that the statements are reasonable, it can give no assurances that such expectations will prove to be correct. Investors are cautioned that any forward looking statements made by the Company, or contained in any and/or all profile/research reports, contain no guarantee of future performance, and that the actual result may differ materially from those set forth in the forward-looking statements. Difference in results can be caused by various factors including, but not limited to, the Company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward looking statements.” Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating certain actions “may,” “could,” or “might” occur. We encourage our readers and viewers to invest carefully and review all forms of investments and read the investor information.